Dianne E Campbell
Overview
Explore the profile of Dianne E Campbell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
128
Citations
1753
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pongracic J, Gagnon R, Sussman G, Siri D, Oriel R, Brown-Whitehorn T, et al.
J Allergy Clin Immunol Pract
. 2025 Mar;
PMID: 40023371
Background: Due to limited treatment options for peanut allergy, patients remain at risk for allergic reactions due to accidental exposure. Epicutaneous immunotherapy (EPIT) is a novel treatment being investigated for...
2.
Greenhawt M, Albright D, Anvari S, Arends N, Arkwright P, Begin P, et al.
J Allergy Clin Immunol Pract
. 2025 Feb;
PMID: 39956162
Background: The pivotal phase 3 EPITOPE trial, a 12-month, double-blind, placebo-controlled study of epicutaneous immunotherapy with the VIASKIN patch containing 250 μg of peanut protein (VP250), previously reported significant treatment...
3.
Baker M, Ford L, Campbell D, Sampson H
Pediatr Allergy Immunol
. 2025 Feb;
36(2):e70038.
PMID: 39953855
The skin is a large and sophisticated organ populated by innate and adaptive immune effector cells. These immune cells provide a critical first line of defense against pathogens, but genetic...
4.
Shwe Yee N, Ng H, Zeng J, Bao J, Campbell D, Turner P, et al.
Foods
. 2024 Nov;
13(21).
PMID: 39517224
Following successful oral immunotherapy (OIT) for peanut allergy using boiled peanuts (BOPI trial), this study investigated the potential of wet-thermal-processing-induced allergen modification, specifically soaking and boiling (1-4 h) to reduce...
5.
Suarez-Farinas M, Grishin A, Arif-Lusson R, Bourgoin P, Matthews K, Campbell D, et al.
J Allergy Clin Immunol Pract
. 2024 Sep;
12(12):3383-3392.e8.
PMID: 39284563
Background: The basophil activation test (BAT) has been limited to research settings owing to technical issues. Novel approaches using dry, ready-to-use reagents and streamlined protocols offer greater flexibility and may...
6.
Perez Chacon G, Estcourt M, Totterdell J, Marsh J, Perrett K, Campbell D, et al.
PLoS Med
. 2024 Jun;
21(6):e1004414.
PMID: 38857311
Background: In many countries, infant vaccination with acellular pertussis (aP) vaccines has replaced use of more reactogenic whole-cell pertussis (wP) vaccines. Based on immunological and epidemiological evidence, we hypothesised that...
7.
Petroni D, Begin P, Bird J, Brown-Whitehorn T, Chong H, Fleischer D, et al.
JAMA Pediatr
. 2024 Feb;
178(4):345-353.
PMID: 38407859
Importance: No approved treatment exists for allergen-specific immunoglobulin E (IgE)-mediated cow's milk allergy (CMA), a common childhood food allergy. Objective: To assess dose, efficacy, and safety of epicutaneous immunotherapy with...
8.
Turner P, Ansotegui I, Campbell D, Cardona V, Carr S, Custovic A, et al.
World Allergy Organ J
. 2024 Feb;
17(3):100876.
PMID: 38361745
There is a lack of consensus over the description and severity assignment of allergic adverse reactions to immunotherapy, although there seems to be a consensus at least in terms of...
9.
Herve P, Dioszeghy V, Matthews K, Bee K, Campbell D, Sampson H
Front Allergy
. 2023 Nov;
4:1290003.
PMID: 37965375
Given the potent immunological properties of the skin, epicutaneous immunotherapy (EPIT) emerges as a promising treatment approach for inducing immune tolerance, particularly for food allergies. Targeting the highly immunocompetent, non-vascularized...
10.
Tanno L, Worm M, Ebisawa M, Ansotegui I, Senna G, Fineman S, et al.
World Allergy Organ J
. 2023 Nov;
16(10):100821.
PMID: 37915955
Background: Anaphylaxis is the most severe clinical presentation of acute systemic allergic reactions and can cause death. Given the prevalence of anaphylaxis within healthcare systems, it is a high priority...